2021 Online, In the cloud

Meeting information
Program
Abstracts

Programme Item
Presenter
Abstract Category
Search Abstract

III-33 Alan Faraj
Phase-3 dose selection of marzeptacog alfa (activated) in children enabled by model-informed drug development techniques